Case report describes dupilumab's impact on severe epidermolysis bullosa simplex in an infant, suggesting new treatment options.
This case report describes treatment with dupilumab in an infant patient with generalized severe epidermolysis bullosa simplex due to a pathogenic variant.
No takes yet. Share an insight, caveat, or question.
Crespi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: